ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research2020

Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus.

Christopher G Fawsitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.